NX35 Trademark

Trademark Overview

On Monday, September 11, 2023, a trademark application was filed for NX35 with the United States Patent and Trademark Office. The USPTO has given the NX35 trademark a serial number of 98174206. The federal status of this trademark filing is REGISTERED as of Tuesday, March 11, 2025. This trademark is owned by SickScience Labs, Inc.. The NX35 trademark is filed in the Cosmetics & Cleaning Products category with the following description:

peptide complex sold as a component ingredient of cosmetic and non-medicated toiletry preparations
nx35

General Information

Serial Number98174206
Word MarkNX35
Filing DateMonday, September 11, 2023
Status700 - REGISTERED
Status DateTuesday, March 11, 2025
Registration Number7725489
Registration DateTuesday, March 11, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 11, 2024

Trademark Statements

Pseudo MarkNX THREE FIVE; NX THIRTY FIVE
Goods and Servicespeptide complex sold as a component ingredient of cosmetic and non-medicated toiletry preparations

Classification Information

International Class003 - Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring and abrasive preparations; soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices.
US Class Codes001, 004, 006, 050, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 2, 2023
Primary Code003
First Use Anywhere DateTuesday, February 27, 2024
First Use In Commerce DateTuesday, February 27, 2024

Trademark Owner History

Party NameSickScience Labs, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDover, DE 19901
Party NameSickScience Labs, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDover, DE 19901
Party NameSickScience Labs, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDover, DE 19901

Trademark Events

Event DateEvent Description
Thursday, September 14, 2023NEW APPLICATION ENTERED
Monday, October 2, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 6, 2024ASSIGNED TO EXAMINER
Wednesday, May 8, 2024EXAMINERS AMENDMENT -WRITTEN
Wednesday, May 8, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, May 8, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, May 8, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, May 8, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 11, 2024PUBLISHED FOR OPPOSITION
Wednesday, May 22, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 6, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 11, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, August 19, 2024USE AMENDMENT FILED
Monday, August 19, 2024TEAS STATEMENT OF USE RECEIVED
Wednesday, October 23, 2024STATEMENT OF USE PROCESSING COMPLETE
Monday, August 19, 2024TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, October 23, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, October 26, 2024NON-FINAL ACTION E-MAILED
Saturday, October 26, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 15, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, October 26, 2024SU - NON-FINAL ACTION - WRITTEN
Wednesday, January 15, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 27, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 27, 2025AMENDMENT/PETITION AFTER APPROVAL FOR PUB ENTERED
Monday, January 27, 2025ASSIGNED TO LIE
Tuesday, February 18, 2025SU-EXAMINER'S AMENDMENT WRITTEN
Tuesday, February 18, 2025EXAMINER'S AMENDMENT ENTERED
Tuesday, February 18, 2025EXAMINERS AMENDMENT E-MAILED
Tuesday, February 18, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, February 18, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, February 18, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 11, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, March 11, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

medicated toiletry preparations cosmetic ingredient complex sold component peptide